5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Insulinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artner, I; Gerrish, K; Samaras, SE; Stein, R; Van Velkinburgh, JC | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Insulinoma
| Article | Year |
|---|---|
Interactions between areas I and II direct pdx-1 expression specifically to islet cell types of the mature and developing pancreas.
Topics: Animals; Animals, Newborn; Base Sequence; Binding Sites; Cell Differentiation; Cell Line; Cell Nucleus; Chromatin; Chromatin Immunoprecipitation; DNA Mutational Analysis; Enhancer Elements, Genetic; Galactosides; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Immunohistochemistry; Indoles; Insulin; Insulinoma; Islets of Langerhans; Lac Operon; Mice; Molecular Sequence Data; NIH 3T3 Cells; Nuclear Proteins; Pancreas; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Transgenes; Zebrafish Proteins | 2005 |